FDLE case update: Pace Pharmacy owners rearrested in FDLE’s ongoing pill mill investigation - fdle.state.fl.us
Pace Pharmacy owners have been rearrested in an ongoing FDLE investigation into pill mills, indicating heightened scrutiny on pharmacies involved in controlled substances.
Aforeworn detected this change in the Pharmacy & Controlled Substances space on September 3, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated High urgency. All pharmacies involved in dispensing controlled substances, particularly independent and compounding pharmacies. should confirm how it applies to their specific situation before acting. There is a time constraint attached: Immediate review and action required due to ongoing investigation.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Pharmacy & Controlled Substances continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
Increased regulatory scrutiny and potential legal consequences for pharmacies involved in the dispensing of controlled substances.
Who it affects
All pharmacies involved in dispensing controlled substances, particularly independent and compounding pharmacies.
What you must do
Review compliance with state and federal regulations regarding controlled substances and ensure all practices align with legal standards.
Deadline
Immediate review and action required due to ongoing investigation.
Never miss a change like this again
Aforeworn watches Pharmacy & Controlled Substances around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Pharmacy & Controlled Substances
- New Maine law recognizes pharmacists as health care providers - une.edu
- Florida pharmacists receive approval to provide COVID-19 vaccines - wusf.org
- Express Scripts Launches Court Fight on Arkansas Pharmacy Law - news.bloomberglaw.com
- Determination That PHENAPHEN WITH CODEINE NO. 3 (Acetaminophen; Codeine Phosphate) Oral Capsules, 325 Milligrams and 30 Milligrams, and PHENAPHEN WITH CODEINE NO. 4 (Acetaminophen; Codeine Phosphate) Oral Capsules, 325 Milligrams and 60 Milligrams, Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness
- Pharmacies may violate civil rights if they refuse meds linked to abortion, feds warn - NPR